Literature DB >> 31933858

Hypoxia-induced EPHB2 promotes invasive potential of glioblastoma.

Wenjin Qiu1, Shibin Song1, Wei Chen1, Jiale Zhang2, Hua Yang1, Yimin Chen1.   

Abstract

EphB2, a receptor tyrosine kinase for ephrin ligands, is overexpressed in various cancers and plays an important role in tumor progression. EPHB2 promotes endothelial-mesenchymal transition (EMT) and elicits associated pathologic characteristics of glioblastoma multiforme (GBM) such as invasion and migration. However, the mechanisms of the EPHB2 regulatory network in glioma remain enigmatic. Here, we report that EPHB2 is epigenetically overexpressed in hypoxia, a condition highly prevalent in malignancy. Furthermore, HIF-2α is required for EPHB2 stabilization by hypoxia. Lastly, we discovered that the overexpression of EPHB2 promotes GBM invasion by the phosphorylation of paxillin in hypoxia. These findings establish the HIF-2α-EPHB2-paxillin axis as a regulatory mechanism of epithelial-mesenchymal transition. IJCEP
Copyright © 2019.

Entities:  

Keywords:  EPHB2; Hypoxia; glioblastoma; invasion; paxillin

Year:  2019        PMID: 31933858      PMCID: PMC6945092     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

Review 1.  Eph receptors and ephrins: regulators of guidance and assembly.

Authors:  D G Wilkinson
Journal:  Int Rev Cytol       Date:  2000

2.  EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion.

Authors:  Mitsutoshi Nakada; Jared A Niska; Nhan L Tran; Wendy S McDonough; Michael E Berens
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.

Authors:  Derek R Johnson; Allison M Sawyer; Christina A Meyers; Brian Patrick O'Neill; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2012-04-16       Impact factor: 12.300

4.  Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.

Authors:  Ting Wang; Daniele M Gilkes; Naoharu Takano; Lisha Xiang; Weibo Luo; Corey J Bishop; Pallavi Chaturvedi; Jordan J Green; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-17       Impact factor: 11.205

5.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

Authors:  A J Wong; S H Bigner; D D Bigner; K W Kinzler; S R Hamilton; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.

Authors:  Haina Qin; Roberta Noberini; Xuelu Huan; Jiahai Shi; Elena B Pasquale; Jianxing Song
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

7.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

Review 8.  Eph receptors and ephrins: effectors of morphogenesis.

Authors:  N Holder; R Klein
Journal:  Development       Date:  1999-05       Impact factor: 6.868

9.  NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme.

Authors:  Chia-Hung Hsieh; Woei-Cherng Shyu; Chien-Yi Chiang; Jung-Wen Kuo; Wu-Chung Shen; Ren-Shyan Liu
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

10.  Epithelial-mesenchymal transition in glioblastoma progression.

Authors:  Yasuo Iwadate
Journal:  Oncol Lett       Date:  2016-01-14       Impact factor: 2.967

View more
  6 in total

Review 1.  Necrotic reshaping of the glioma microenvironment drives disease progression.

Authors:  Steven M Markwell; James L Ross; Cheryl L Olson; Daniel J Brat
Journal:  Acta Neuropathol       Date:  2022-01-17       Impact factor: 15.887

2.  EPHB2 as a recurrence-related gene and a prognostic indicator in nasopharyngeal carcinoma: A bioinformatics screening and immunohistochemistry verification.

Authors:  Junjun Ling; Aoshuang Chang; Houyu Zhao; Huiping Ye; Xianlu Zhuo
Journal:  Histol Histopathol       Date:  2022-04-20       Impact factor: 2.130

Review 3.  The Roles of EphB2 in Cancer.

Authors:  Wei Liu; Chengpeng Yu; Jianfeng Li; Jiwei Fang
Journal:  Front Cell Dev Biol       Date:  2022-02-10

Review 4.  Sirtuins and Hypoxia in EMT Control.

Authors:  Michele Aventaggiato; Federica Barreca; Luigi Sansone; Laura Pellegrini; Matteo A Russo; Marco Cordani; Marco Tafani
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-10

Review 5.  Mesenchymal Transformation: The Rosetta Stone of Glioblastoma Pathogenesis and Therapy Resistance.

Authors:  Zulfikar Azam; Shing-Shun Tony To; Bakhos A Tannous
Journal:  Adv Sci (Weinh)       Date:  2020-09-28       Impact factor: 16.806

6.  PRL1 Promotes Glioblastoma Invasion and Tumorigenesis via Activating USP36-Mediated Snail2 Deubiquitination.

Authors:  Wenjin Qiu; Xiaomin Cai; Kaya Xu; Shibin Song; Zumu Xiao; Yunan Hou; Xiaolan Qi; Feng Liu; Yimin Chen; Hua Yang; Liangzhao Chu; Jian Liu
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.